Significance of melanin binding and metabolism in the activity of 5-acetoxyacetylimino-4-methyl-delta2-1,3,4,-thiadiazolin e-2-sulfonamide.
5-Acetoxyacetylimino-4-methyl-delta2-1,3,4,-thiadiazoline -2-sulfonamide (compound (1)) is an ester prodrug that lowered intraocular pressure (IOP) in albino New Zealand rabbits, but was found to be inactive in pigmented Dutch Belt rabbits. In order to explain the differences in pharmacological activity for the two rabbit species, metabolism and melanin binding were studied. Depending on the initial concentration, the binding of compound (1) to natural melanin (Sepia officinalis) was 20-60%. The binding constant, K, at 37 degrees C was 4.32 x 10(5) M(-1) and the maximum moles bound to melanin, r(max), was 4.5 x 10(-7) mol/mg of melanin. From a determination of binding at temperatures between 25 degrees C and 47 degrees C, a van't Hoff plot was constructed to determine enthalpy and entropy changes accompanying the binding process, deltaH and deltaS, respectively. Values calculated from the plot were -12.7 and -15.4 kcal/(mol deg), respectively. Negative values for these parameters are consistent with charge transfer interactions and therefore suggest that this may be an operative mechanism between compound (1) and melanin. The in vitro incubation of compound (1) was also studied with various ocular tissues from both albino and pigmented rabbits which were iris-ciliary body, intact cornea, stroma/endothelium and aqueous humor. A major metabolite, MET 1, was identified and also observed from in vivo analyses of the same tissues following topical application. The metabolite was isolated and subjected to mass spectroscopy and proton nuclear magnetic resonance spectroscopy analysis. From these analyses, it was hypothesized that the formation of MET 1 involved a GSH conjugation mechanism which displaced the sufonamide (-SO2NH2) group. The metabolism was found to be less extensive in the pigmented rabbit than in the albino rabbit and suggested that the binding affinity of compound (1) for melanin was a better explanation for the lack of IOP activity in the pigmented rabbit than differences in metabolism.
Schoenwald
R D
RD
Division of Pharmaceutics, The University of Iowa, Iowa City 52242-1112, USA.
Tandon
V
V
Wurster
D E
DE
Barfknecht
C F
CF
D000818:Animals; D002257:Carbonic Anhydrase Inhibitors / Q000378:metabolism* / Q000494:pharmacology*; D002256:Carbonic Anhydrases / Q000378:metabolism; D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid; D005123:Eye / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D013058:Mass Spectrometry; D008543:Melanins / Q000378:metabolism*; D008704:Methazolamide / Q000378:metabolism / Q000494:pharmacology; D011817:Rabbits; D013696:Temperature; D013830:Thiadiazoles / Q000378:metabolism* / Q000494:pharmacology
C115288:5-acetoxyacetylimino-4-methyl-delta(2)-1,3,4-thiadiazoline-2-sulfonamide; D002257:Carbonic Anhydrase Inhibitors; D008543:Melanins; D013830:Thiadiazoles; D002256:Carbonic Anhydrases; D008704:Methazolamide